No-Touch Pancreatectomy for Invasive Ductal Carcinoma of the Pancreas
Abstract
Background Pancreatectomy is the only effective treatment for cancers of the pancreas. Surgeons usually grasp tumors during pancreatectomy; however, this procedure may increase the risk of squeezing and shedding of the cancer cells into the portal vein, retroperitoneum, and/or peritoneal cavity. In an effort to overcome these problems, we have developed surgical techniques for no-touch pancreatectomy. Methods From April 2008 through September 2013, 52 patients have been operated on no-touch pancreatectomy for invasive ductal carcinoma of the pancreas by a single operator (M.H.). Among them, 40 received pancreatoduodenectomy (PD), and 12 did distal pancreatectomy (DP). Twenty two cases (42%) required SMV-PV resection. This is a study to see if pancreatectomy can be technically done using a no-touch surgical technique without deteriorating the post-operative prognosis. During the procedure, the pancreatic tumor is neither grasped nor squeezed by the surgeon. Furthermore, for improved dissection of the retroperitoneal tissue (leftward and posterior margins for PD and rightward and posterior margins for DP), we use a hanging and clamping maneuver and dissection behind Gerota fascia. Results Overall 2- and 5-year survival rates were 64 and 42% with mean follow-up periods of 34.4 months (range: 6-68 months). Recurrence free 2- and 5-year survival rates were 49 and 31%, respectively. The 5-year survival rates of patients with JPS-stage III and those with JPS-stage IV were 57 and 20%, respectively. The 5-year survival rates of patients with UICC-stage IIA and those with UICC- stage IIB were 49 and 39%, respectively. Patients with UICC-stage III or IV did not survive for more than 2 years. Conclusions No-touch pancreatectomy has many theoretic advantages that merit further investigation in future randomized controlled trials.
Image: Tissue slice along the clamp.
Downloads
References
Barnes JP. Physiologic resection of the right colon. Surg Gynecol Obstet. 1952; 94(6):722-6. [PMID:14931182]
Turnbull RB Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg. 1967; 166:420-427. [PMID:6039601]
Hirota M, Shimada S, Yamamoto K, Tanaka E, Sugita H, Egami H, Ogawa M. Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. JOP. 2005; 6:143-151. [PMID:15767730]
Hirota M, Kanemitsu K, Takamori H, Chikamoto A, Tanaka H, Sugita H, Sand J, et al. Pancreatoduodenectomy using a no-touch isolation technique. Am J Surg. 2010; 199:e65-e68. [PMID:19095210]
Hirota M, Hashimoto D, Ishiko T, Satoh N, Takamori H, Chikamoto A, Tanaka H, et al. Distal pancreatectomy using a no-touch isolation technique. Scand J Surg. 2012; 101:156-159. [PMID:22968237]
Fortner JG, Kim DK, Cubilla A, Turnbull A, Pahnke LD, Shils ME. Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection. Ann Surg. 1977; 186:42-50. [PMID:195543]
Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, Pitt HA, et al. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg. 1999; 229:613-622. [PMID:10235519]
Weitz J, Kienle P, Schmidt J, Friess H, Büchler MW. Portal vein resection for advanced pancreatichead cancer. J Am Coll Surg. 2007; 204:712-716. [PMID:17382233]
Mizuno S, Isaji S, Tanemura A, et al. Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma. J Gastrointest Surg 2014 Mar25. [Epub ahead of print].
Shoup M, Conlon KC, Klimstra D, Brennan ME. Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J Gastrointest Surg. 2003; 240: 214-215. [PMID:14675703]
Christein JD, Kendrick ML, Iqbal CW, Nagorney DM, Farnell MB. Distal pancreatectomy for respectable adenocarcinoma of the body and tail of the pancreas. J Gastrointest Surg. 2005; 9:922-927. [PMID:16137585]
Shimada K, Sakamoto Y, Sano T, Kosuge T. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail. Surgery. 2006; 139:288-295. [PMID:16546491]
Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Ohge H, Sueda T. Impact of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for adenocarcinoma of the body or tail of the pancreas. J Gastrointest Surg. 2009; 13:85-92. [PMID:18704593]
Fujita T, Nakagohri T, Gotohda N, Takahashi S, Konishi M, Kojima M, Kinoshita T. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas. 2010; 39:e48-54. [PMID:19910836]
Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009; 16:1727-1733. [PMID:19396496]
Springett GM, Hoffe SE. Borderline resectable pancreatic cancer: on the edge of survival. Cancer Control. 2008; 15:295-307. [PMID:18813197]
Nakao A, Takagi H. Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology. 1993; 40:426-429. [PMID:8270230]
Yamamoto K, Shimada S, Hirota M, Yagi Y, Matsuda M, Baba H. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. Int J Oncol. 2005; 27:1321-1328. [PMID:16211228]
Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003; 133:521-527. [PMID:12773980]
Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability of obtain negative tangential margins. J Am Coll Surg. 2007; 204:244-249. [PMID:17254928]
Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redifining the R1 resection in pancreatic cancer. Br J Surg. 2006; 93:1232-1237. [PMID:16804874]
Ishikawa O, Wada H, Ohigashi H, Doki Y, Yokoyama S, Noura S, Yamada T, et al. Postoperative cytology for drained fluid from the pancreatic bed after “curative “ resection of pancreatic cancers: does it predict both the patient’s prognosis and the site of cancer recurrence? Ann Surg. 2003; 238:103-110. [PMID:12832972]
Imamura Y, Hirota M, Ida S, Hayashi N, Watanabe M, Takamori H, Awai K, et al. Significance of renal rim grade on computed tomography in severity evaluation of acute pancreatitis. Pancreas. 2010; 39:41-46. [PMID:19745776]
Weitz J, Kienle P, Schmidt J, Friess H, Büchler MW. Portal vein resection for advanced pancreatic head cancer. J Am CollSurg. 2007; 204:712-716. [PMID:17382233]
Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004; 91:586-594. [PMID:15122610]
Hartel M, Wente MN, Di Sebastiano P, Friess H, Büchler MW. The role of extended resection in pancreatic adenocarcinoma: is there good evidence-based justification? Pancreatology. 2004; 4:561-566. [PMID:15550765]
Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, Madura JA, et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 2006; 10:1338-1346. [PMID:17175452]
Dumitrascu T, David L, Popescu I. Posterior versus standard approach in pancreatoduodenectomy: a case-match study. Langenbecks Arch Surg. 2010; 395: 677-84.
Copyright (c) 2014 Masahiko Hirota, Michio Ogawa
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.